I am a
Home I AM A Search Login

Papers of the Week

2020 Feb 22


Short and Mid-Term Predictors of Response to OnabotulinumtoxinA: Real-Life Experience Observational Study.


Alpuente A, Gallardo V J, Torres-Ferrús M, Álvarez-Sabin J, Pozo-Rosich P
Headache. 2020 Feb 22.
PMID: 32086801.


To identify clinical predictors of excellent response to OnabotulinumtoxinA in patients with chronic migraine (CM) at 6 and 12 months of follow-up.